logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Christine W Czarniecki

This inventor holds 2 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 1992-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine W Czarniecki. Retrieved from https://idiyas.com/inventor/christine-w-czarniecki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 131(Granted Patents)


Company Filing History:

goldMedal2 out of 3,302 
 
Genentech, Inc.
 patents

Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents
1. 5248499 - Control of microbial infections in transplant patients (1993-09-28),
2. 5135915 - Method for the treatment of grafts prior to transplantation using TGF-.beta (1992-08-04),

Title: Christine W Czarniecki: Innovator in Transplant Medicine

Introduction

Christine W Czarniecki is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of transplant medicine, particularly in the prevention and treatment of microbial infections in transplant patients. With a total of 2 patents, her work has the potential to greatly improve patient outcomes in this critical area of healthcare.

Latest Patents

Czarniecki's latest patents include innovative methods aimed at enhancing the safety and efficacy of transplant procedures. One of her notable inventions is focused on the "Control of microbial infections in transplant patients." This invention addresses the prevention and treatment of microbial infections in transplant recipients through the use of lymphokines, specifically gamma interferon (IFN-.gamma.), without increasing the incidence of graft rejections. Another significant patent is the "Method for the treatment of grafts prior to transplantation using TGF-.beta." This method involves treating grafts such as tissues or organs with TGF-.beta. to induce biological effects before transplantation into a compatible host.

Career Highlights

Christine W Czarniecki is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. Her work at Genentech has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in transplant medicine.

Collaborations

Some of her notable coworkers include Jon B Klein and A David Slater. Their collaborative efforts have further advanced the research and development of effective treatments for transplant patients.

Conclusion

Christine W Czarniecki's contributions to the field of transplant medicine through her patents and work at Genentech, Inc. highlight her dedication to improving patient care. Her innovative approaches have the potential to transform the landscape of transplant procedures and enhance the quality of life for many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…